-
NSE
2,074.00 2,074.00(%) -
Kaynes Tech
2,780.00 2,780.00(%) -
SBI
1,099.70 1,234.80(%) -
Lenskart Solut.
745.90 767.40(%) -
HDFC Bank
817.80 1,017.90(%) -
M & M
3,360.00 3,840.00(%) -
Millworks Technologies
691.20 628.90(%) -
Kalyan Jewellers
729.00 729.00(%) -
Cholaman.Inv.&Fn
1,829.90 1,299.80(%) -
Knowledge Realty
111.84 129.49(%) -
Persistent Systems
5,943.15 4,242.65(%) -
ICICI Bank
1,577.05 1,187.55(%) -
Jio Platforms
1,433.70 1,490.00(%) -
Sai Life
1,785.65 786.15(%) -
Cupid
360.30 60.62(%) -
Eicher Motors
7,521.00 6,439.45(%) -
Kotak Mah. Bank
497.90 497.90(%) -
Belrise Industri
242.15 268.00(%) -
Hitachi Energy
30,665.00 16,104.00(%) -
LIC Housing Fin.
608.40 608.40(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Auro Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs
- Indian Private
- BSE Code : 4899.0
- ISIN : INE292C01011
-
Today’s Low
230.05 -
Today’s High
243.00
-
Open
238.00 -
Perv Close
234.30 -
52W Low
199.95 -
52W High
317.00
Key Indicators
-
P/E(TTM)
27.99
-
Mar.Cap (₹Cr.)
146.53
-
Div & Yield %
0.00
-
Book Value(₹)
77.92
-
Debt-Equity Ratio
0.34
-
AGM Date
16-Nov-2026
-
EPS
8.40
-
P/E Ratio
27.99
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
146.53
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
6.23
-
BV (₹)
77.90
-
Sales( ₹ in Cr.)
30.74
-
NP (in Cr.)
3.79
-
NP Var(%)
106.0
-
Div%
0.0
-
CPS (₹)
10.60
-
EPS (₹)
6.10
-
Traded Value (₹ in Lakhs)
146.53
-
52 Week High
317.00
-
52 Week Low
199.95
-
Price BSE
235.0
-
Price NSE
0.00
-
Market Capital( in Cr.)
146.53
-
P/C Ratio
22.20
-
P/E Ratio
38.70
-
Price Vs.BV
6.10
-
01-Jul-2026( 04:21)
Corporate News - Auro... - Auro Laboratories announced th...
-
30-May-2026( 09:25)
Results - Announcements - Auro... - Net profit of Auro Laboratorie...
-
26-May-2026( 01:58)
Corporate News - Auro... - Auro Laboratories will hold a...
-
06-Feb-2026( 07:40)
Results - Announcements - Auro... - Net profit of Auro Laboratorie...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 30.74 | 19.12 | 53.64 | 52.89 | 50.87 | 54.25 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 30.74 | 19.12 | 53.64 | 52.89 | 50.87 | 54.25 |
| Other Income | 2.01 | 0.93 | 1.50 | 0.94 | 1.09 | 0.76 |
| Stock Adjustments | 8.23 | -4.13 | 2.48 | 1.61 | 0.98 | -0.91 |
| Total Income | 40.98 | 15.92 | 57.62 | 55.44 | 52.94 | 54.10 |
| EXPENDITURE : | ||||||
| Raw Materials | 14.29 | 5.08 | 29.04 | 37.30 | 33.76 | 27.64 |
| Power and Fuel Cost | 1.85 | 0.33 | 2.43 | 2.08 | 1.67 | 1.60 |
| Employee Cost | 5.86 | 2.47 | 3.91 | 3.76 | 3.70 | 3.64 |
| Other Manufacturing Expenses | 0.42 | 0.10 | 0.56 | 1.42 | 1.76 | 2.10 |
| Selling and Administration Expenses | 5.44 | 2.89 | 7.91 | 4.73 | 5.86 | 5.84 |
| Miscellaneous Expenses | 1.25 | 1.01 | 1.60 | 0.82 | 0.48 | 1.29 |
| Employee Benefit Expenses | 5.86 | 2.47 | 3.91 | 3.76 | 3.70 | 3.64 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 29.11 | 11.87 | 45.45 | 50.11 | 47.22 | 42.10 |
| Operating Profit | 11.87 | 4.06 | 12.18 | 5.33 | 5.72 | 12.00 |
| Interest | 4.25 | 1.08 | 0.74 | 0.81 | 0.83 | 0.46 |
| Gross Profit | 7.62 | 2.98 | 11.44 | 4.52 | 4.89 | 11.54 |
| Depreciation | 2.81 | 1.10 | 1.09 | 1.07 | 1.02 | 1.04 |
| Profit Before Tax | 4.81 | 1.88 | 10.35 | 3.45 | 3.87 | 10.50 |
| Current Tax | 0.00 | 0.10 | 2.74 | 1.00 | 1.07 | 3.20 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.28 | -0.06 | -0.19 | 0.00 | -0.04 | 0.12 |
| Reported Net Profit | 3.53 | 1.84 | 7.79 | 2.44 | 2.84 | 7.18 |
| Extraordinary Items | -0.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Net Profit | 3.79 | 1.84 | 7.79 | 2.44 | 2.84 | 7.18 |
| Adjustment below Net Profit | 0.00 | -0.95 | -0.03 | 0.24 | 0.09 | -0.09 |
| P & L Balance brought forward | 35.95 | 35.06 | 27.30 | 24.62 | 21.68 | 14.60 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 39.48 | 35.95 | 35.06 | 27.30 | 24.62 | 21.68 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 5.67 | 2.95 | 12.50 | 3.92 | 4.56 | 11.52 |
| Earnings Per Share(Adj)-Unit Curr | 5.67 | 2.95 | 12.50 | 3.92 | 4.56 | 11.52 |
| Book Value | 74.36 | 68.94 | 67.32 | 54.87 | 50.58 | 45.86 |
| Book Value(Adj)-Unit Curr | 74.36 | 68.94 | 67.32 | 54.87 | 50.58 | 45.86 |
